In last trading session, Generation Bio Co (NASDAQ:GBIO) saw 0.82 million shares changing hands with its beta currently measuring 2.72. Company’s recent per share price level of $0.37 trading at -$0.03 or -6.29% at ring of the bell on the day assigns it a market valuation of $24.96M. That closing price of GBIO’s stock is at a discount of -1121.62% from its 52-week high price of $4.52 and is indicating a premium of 2.7% from its 52-week low price of $0.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.56 million shares which gives us an average trading volume of 525.54K if we extend that period to 3-months.
For Generation Bio Co (GBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.25 in the current quarter.
Generation Bio Co (NASDAQ:GBIO) trade information
Upright in the red during last session for losing -6.29%, in the last five days GBIO remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $0.37 price level, adding 15.91% to its value on the day. Generation Bio Co’s shares saw a change of -64.86% in year-to-date performance and have moved -12.93% in past 5-day. Generation Bio Co (NASDAQ:GBIO) showed a performance of -28.71% in past 30-days. Number of shares sold short was 1.68 million shares which calculate 4.0 days to cover the short interests.
Generation Bio Co (GBIO) estimates and forecasts
This year revenue growth is estimated to fall -71.44% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.7M for the same. And 5 analysts are in estimates of company making revenue of 1.7M in the next quarter. Company posted 4.06M and 4.09M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -8.30% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 43.69% while estimates for its earnings growth in next 5 years are of 25.87%.
Generation Bio Co (NASDAQ:GBIO)’s Major holders
Insiders are in possession of 14.35% of company’s total shares while institution are holding 81.47 percent of that, with stock having share float percentage of 95.13%. Investors also watch the number of corporate investors in a company very closely, which is 81.47% institutions for Generation Bio Co that are currently holding shares of the company. PRICE T ROWE ASSOCIATES INC /MD/ is the top institutional holder at GBIO for having 9.51 million shares of worth $26.83 million. And as of 2024-06-30, it was holding 14.3205 of the company’s outstanding shares.
The second largest institutional holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, which was holding about 8.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.4628 of outstanding shares, having a total worth of $23.35 million.
On the other hand, T. Rowe Price New Horizons Fund, Inc. and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 5.34 shares of worth $1.99 million or 7.97% of the total outstanding shares. The later fund manager was in possession of 1.77 shares on Feb 28, 2025 , making its stake of worth around $0.66 million in the company or a holder of 2.65% of company’s stock.
